Megapharm Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Megapharm Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3406
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Megapharm Ltd (Megapharm) is a biotechnology company that offers marketing of pharmaceutical products for international companies. The company markets products in therapeutic areas such as central nervous system, dermatology, gastroenterology, urology, respiratory and allergy, oncology, rheumatology and gynaecology, among others. It provides clinical research services such as safety reporting, clinical monitoring, regulatory guidance, drug import and storage, among others. Megapharm also provides consultation and supervision services to its partners associated with the clinical studies in Israel. The company also operates through its partners located in Ireland, Germany, Switzerland, Cyprus, Austria, the UK and others. Megapharm is headquartered in Raanana, Israel.

Megapharm Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Megapharm Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Megapharm Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Megapharm Enters into Licensing Agreement with Foresee Pharma 10
Pharma Mar Enters into Licensing Agreement with Megapharm 11
Megapharm Enters into Licensing Agreement with MolMed for Zalmoxis 12
Megapharm Enters into Licensing Agreement with XBiotech for Xilonix 13
Megapharm Ltd – Key Competitors 14
Megapharm Ltd – Key Employees 15
Megapharm Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Megapharm Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Megapharm Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Megapharm Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Megapharm Enters into Licensing Agreement with Foresee Pharma 10
Pharma Mar Enters into Licensing Agreement with Megapharm 11
Megapharm Enters into Licensing Agreement with MolMed for Zalmoxis 12
Megapharm Enters into Licensing Agreement with XBiotech for Xilonix 13
Megapharm Ltd, Key Competitors 14
Megapharm Ltd, Key Employees 15

List of Figures
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Megapharm Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Megapharm Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ormat Technologies Inc (ORA):企業の財務・戦略的SWOT分析
    Ormat Technologies Inc (ORA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The Tata Power Co Ltd (TATAPOWER):企業の財務・戦略的SWOT分析
    The Tata Power Co Ltd (TATAPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Stemline Therapeutics Inc (STML):企業の財務・戦略的SWOT分析
    Summary Stemline Therapeutics Inc (Stemline) is a clinical stage biopharmaceutical company that develops therapeutics to treat cancer stem cells and tumor bulk. The company has developed discovery platform StemScreen to identify novel compounds that target and kill cancer stem cells. Its products pi …
  • Metso Corporation:企業の戦略・SWOT・財務情報
    Metso Corporation - Strategy, SWOT and Corporate Finance Report Summary Metso Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Blueprint Medicines Corp (BPMC):企業の財務・戦略的SWOT分析
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, discovers and develops precision therapies for the treatment of cancers and rare diseases. The company offers AYVAKIT (avapritinib) medicine to treat gastrointestinal stromal tumor (GIST); and GAVRETO (pralse …
  • Polimex-Mostostal SA (PXM):企業の財務・戦略的SWOT分析
    Polimex-Mostostal SA (PXM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Neiman Marcus Group LTD LLC:企業の戦略的SWOT分析
    Neiman Marcus Group LTD LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Hutchison China Meditech Ltd:企業の戦略・SWOT・財務分析
    Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report Summary Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • eNeura Inc:医療機器:M&Aディール及び事業提携情報
    Summary eNeura Inc (eNeura) formerly eNeura Therapeutics LLC is a medical device manufacturing company that offers portable, non-invasive transcranial magnetic stimulation devices for treating migraine. The company offers products such as flagship product and eNeura Spring TMS device, among others. …
  • Red Rock Resorts, Inc. (RRR):企業の財務・戦略的SWOT分析
    Red Rock Resorts, Inc. (RRR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • RCR Tomlinson Ltd (RCR):企業の財務・戦略的SWOT分析
    RCR Tomlinson Ltd (RCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Atlas Air Worldwide Holdings Inc:企業の戦略・SWOT・財務分析
    Atlas Air Worldwide Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Atlas Air Worldwide Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • MDNA Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test (PCMT) based on the science of mitochondrial DNA (mtDNA) is a tissue-based prostate cancer diagnostics for prostate and o …
  • Morphotek Inc:企業のM&A・事業提携・投資動向
    Morphotek Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Morphotek Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Enterprise Diversified Inc (SYTE):企業の財務・戦略的SWOT分析
    Summary Enterprise Diversified Inc (Enterprise Diversified), formerly Sitestar Corp, is a technology company that offers asset management, home services, internet, and real estate programs. The company offers consumer and business-grade internet access, wholesale managed modem services for downstrea …
  • BrightSpring Health Services:企業の戦略的SWOT分析
    BrightSpring Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Eiken Chemical Co Ltd (4549):企業の製品パイプライン分析2018
    Summary Eiken Chemical Co Ltd (Eiken Chemical), a subsidiary of Hitachi High-Technologies Corp is a medical equipment provider that offers molecular genetic products and medical devices. The company manufactures and markets clinical diagnostics and equipment, among others. It also provides fecal imm …
  • Bunge Ltd (BG):企業の財務・戦略的SWOT分析
    Bunge Ltd (BG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Land Bank of Taiwan Co., Ltd:企業の戦略・SWOT・財務情報
    Land Bank of Taiwan Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Land Bank of Taiwan Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Amarin Corp Plc (AMRN):企業の財務・戦略的SWOT分析
    Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆